DNA testing company 23andMe Inc. was hit last week with a proposed class action in California federal court accusing it of falsely claiming its saliva collection kit can detect genetic-related health problems, a month after the U.S. Food and Drug Administration ordered the company to halt sales of the test.
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Direct access to case information and documents.
All significant new filings across U.S. federal district courts, updated hourly on business days.
Full-text searches on all patent complaints in federal courts.